Medical Mycology, Public Health Laboratories, Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.
J Clin Microbiol. 2010 Dec;48(12):4525-33. doi: 10.1128/JCM.00883-10. Epub 2010 Sep 15.
Nocardia species identification is difficult due to a complex and rapidly changing taxonomy, the failure of 16S rRNA and cellular fatty acid analysis to discriminate many species, and the unreliability of biochemical testing. Here, Nocardia species identification was achieved through multilocus sequence analysis (MLSA) of gyrase B of the β subunit of DNA topoisomerase (gyrB), 16S rRNA (16S), subunit A of SecA preprotein translocase (secA1), the 65-kDa heat shock protein (hsp65), and RNA polymerase (rpoB) applied to 190 clinical, 36 type, and 11 reference strains. Phylogenetic analysis resolved 30 sequence clusters with high (>85%) bootstrap support. Since most clusters contained a single type strain and the analysis corroborated current knowledge of Nocardia taxonomy, the sequence clusters were equated with species clusters and MLSA was deemed appropriate for species identification. By comparison, single-locus analysis was inadequate because it failed to resolve species clusters, partly due to the presence of foreign alleles in 22.1% of isolates. While MLSA identified the species of the majority (71.3%) of strains, it also identified clusters that may correspond to new species. The correlation of the identities by MLSA with those determined on the basis of microscopic examination, biochemical testing, and fatty acid analysis was 95%; however, MLSA was more discriminatory. Nocardia cyriacigeorgica (21.58%) and N. farcinica (14.74%) were the most frequently encountered species among clinical isolates. In summary, five-locus MLSA is a reliable method of elucidating taxonomic data to inform Nocardia species identification; however, three-locus (gyrB-16S-secA1) or four-locus (gyrB-16S-secA1-hsp65) MLSA was nearly as reliable, correctly identifying 98.5% and 99.5% of isolates, respectively, and would be more feasible for routine use in a clinical reference microbiology laboratory.
由于分类学复杂且快速变化、16S rRNA 和细胞脂肪酸分析无法区分许多物种以及生化测试不可靠,因此诺卡氏菌种的鉴定较为困难。在这里,通过对 DNA拓扑异构酶β亚基的回旋酶 B(gyrB)、16S rRNA(16S)、SecA 前蛋白易位子亚基 A(secA1)、65kDa 热休克蛋白(hsp65)和 RNA 聚合酶(rpoB)的多位点序列分析(MLSA)实现了对 190 株临床、36 株模式和 11 株参考菌株的鉴定。系统发育分析确定了 30 个具有高(>85%)置信度的序列簇。由于大多数簇仅包含单一的模式株,且分析结果证实了当前的诺卡氏菌分类学知识,因此这些序列簇与物种簇等同,MLSA 适合用于物种鉴定。相比之下,由于 22.1%的分离株存在外来等位基因,单基因分析不够充分,无法解决物种簇的问题。虽然 MLSA 可以鉴定大多数(71.3%)菌株的物种,但它也可以鉴定可能对应新物种的簇。MLSA 确定的身份与基于显微镜检查、生化测试和脂肪酸分析确定的身份之间的相关性为 95%;然而,MLSA 具有更强的鉴别力。在临床分离株中,最常遇到的物种是触球诺卡氏菌(21.58%)和星形诺卡氏菌(14.74%)。总之,五基因座 MLSA 是阐明分类学数据的可靠方法,有助于诺卡氏菌的种鉴定;然而,三基因座(gyrB-16S-secA1)或四基因座(gyrB-16S-secA1-hsp65)MLSA 也几乎同样可靠,分别正确鉴定了 98.5%和 99.5%的分离株,并且对于临床参考微生物学实验室的常规使用更为可行。